Björnsson ES - Search Results

1

Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials.

Niu H, Sanabria-Cabrera J, Alvarez-Alvarez I, Robles-Diaz M, Stankevičiūtė S, Aithal GP, Björnsson ES, Andrade RJ, Lucena MI. Niu H, et al. Among authors: bjornsson es. Pharmacol Res. 2021 Feb;164:105404. doi: 10.1016/j.phrs.2020.105404. Epub 2020 Dec 24. Pharmacol Res. 2021. PMID: 33359912 Free article.

2

Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic.

De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E. De Valle MB, et al. Aliment Pharmacol Ther. 2006 Oct 15;24(8):1187-95. doi: 10.1111/j.1365-2036.2006.03117.x. Aliment Pharmacol Ther. 2006. PMID: 17014577 Free article.

3

[Drug-induced liver injury].

Björnsson ES. Björnsson ES. Laeknabladid. 2010 Mar;96(3):175-82. doi: 10.17992/lbl.2010.03.280. Laeknabladid. 2010. PMID: 20197596 Free article. Icelandic.

4

Review article: drug-induced liver injury in clinical practice.

Björnsson E. Björnsson E. Aliment Pharmacol Ther. 2010 Jul;32(1):3-13. doi: 10.1111/j.1365-2036.2010.04320.x. Epub 2010 Mar 31. Aliment Pharmacol Ther. 2010. PMID: 20374223 Free article. Review.

5

Case definition and phenotype standardization in drug-induced liver injury.

Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Aithal GP, et al. Clin Pharmacol Ther. 2011 Jun;89(6):806-15. doi: 10.1038/clpt.2011.58. Epub 2011 May 4. Clin Pharmacol Ther. 2011. PMID: 21544079 Review.

6

Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Björnsson ES, et al. Among authors: bjornsson hk. Gastroenterology. 2013 Jun;144(7):1419-25, 1425.e1-3; quiz e19-20. doi: 10.1053/j.gastro.2013.02.006. Epub 2013 Feb 16. Gastroenterology. 2013. PMID: 23419359

7

Drug-induced cholestasis.

Bjornsson ES, Jonasson JG. Bjornsson ES, et al. Clin Liver Dis. 2013 May;17(2):191-209. doi: 10.1016/j.cld.2012.11.002. Epub 2012 Dec 20. Clin Liver Dis. 2013. PMID: 23540497 Review.

8

Epidemiology and risk factors for idiosyncratic drug-induced liver injury.

Björnsson ES. Björnsson ES. Semin Liver Dis. 2014 May;34(2):115-22. doi: 10.1055/s-0034-1375953. Epub 2014 May 31. Semin Liver Dis. 2014. PMID: 24879977 Review.

9

Risk of drug-induced liver injury from tumor necrosis factor antagonists.

Björnsson ES, Gunnarsson BI, Gröndal G, Jonasson JG, Einarsdottir R, Ludviksson BR, Gudbjörnsson B, Olafsson S. Björnsson ES, et al. Clin Gastroenterol Hepatol. 2015 Mar;13(3):602-8. doi: 10.1016/j.cgh.2014.07.062. Epub 2014 Aug 15. Clin Gastroenterol Hepatol. 2015. PMID: 25131534

10

Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trials.

Avigan MI, Bjornsson ES, Pasanen M, Cooper C, Andrade RJ, Watkins PB, Lewis JH, Merz M. Avigan MI, et al. Among authors: bjornsson es. Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S19-31. doi: 10.1007/s40264-014-0183-6. Drug Saf. 2014. PMID: 25352325 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page